31.   The companies would then present counterarguments.

32.   The company today presented studies showing that the drug can significantly reduce breakthrough pain at a faster rate than other pain drugs.

33.   The company also presented studies showing the devices could help prevent further dislocations in patients experiencing multiple hip dislocations, and could reduce pain.

34.   The company will present bondholders an offer to tender their debt and participate in the restructuring in January.

35.   The company must present its findings to the FDA for review.

36.   The company presented data showing the drug was safe, with most side effects being mild.

37.   The commission expects companies to present bids on a distribution permit for the Toluca region in two weeks.

38.   The company also presented data showing that the protein would be destroyed by stomach acids more quickly than had been thought.

39.   The company could present an initial reorganization plan to creditors next month.

40.   The company is presenting the results of clinical studies today to an FDA advisory panel, which will recommend whether the drug should be approved in the U.S.